Respiratory syncytial virus vaccine development

JL Hurwitz - Expert review of vaccines, 2011 - Taylor & Francis
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract viral disease
in infants and young children. Presently, there are no explicit recommendations for RSV …

Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus

SS Bawage, PM Tiwari, S Pillai, V Dennis… - Advances in …, 2013 - Wiley Online Library
Human respiratory syncytial virus (RSV) is a common cause of respiratory infection in infants
and the elderly, leading to significant morbidity and mortality. The interdisciplinary fields …

Chitosan-coated poly (lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine

K Zhao, Y Zhang, X Zhang, C Shi, X Wang… - International journal …, 2014 - Taylor & Francis
We determined the efficacy and safety of chitosan (CS)-coated poly (lactic-co-glycolic) acid
(PLGA) nanoparticles (NPs) as a delivery system for a vaccine to protect chickens against …

Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles

K Zhao, Y Zhang, X Zhang, W Li, C Shi… - International journal …, 2014 - Taylor & Francis
Optimal preparation conditions of Newcastle disease virus (NDV) F gene deoxyribonucleic
acid (DNA) vaccine encapsulated in chitosan nanoparticles (pFNDV-CS-NPs) were …

IgA response and protection following nasal vaccination of chickens with Newcastle disease virus DNA vaccine nanoencapsulated with Ag@SiO2 hollow …

K Zhao, G Rong, Y Hao, L Yu, H Kang, X Wang… - Scientific Reports, 2016 - nature.com
Newcastle disease caused by ND virus (NDV) is a highly contagious disease of birds.
Vaccine for effective protection of poultry animals from NDV infection is urgently needed …

[PDF][PDF] New insights for development of a safe and protective RSV vaccine

JCG Blanco, MS Boukhvalova, KA Shirey… - Human …, 2010 - Taylor & Francis
New insights for development of a safe and protective RSV vaccine Page 1 Human
Vaccines 6:6, 482-492; June 2010; © 2010 Landes Bioscience Commentary 482 Human …

Promising approaches for the treatment and prevention of viral respiratory illnesses

NG Papadopoulos, S Megremis, NA Kitsioulis… - Journal of Allergy and …, 2017 - Elsevier
Viral respiratory tract infections are the most common human ailments, leading to enormous
health and economic burden. Hundreds of viral species and subtypes have been associated …

Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticles

K Zhao, W Li, T Huang, X Luo, G Chen, Y Zhang… - PLoS …, 2013 - journals.plos.org
Background Although the Newcastle disease virus (NDV) inactivated vaccines and
attenuated live vaccines have been used to prevent and control Newcastle disease (ND) for …

Response of live Newcastle disease virus encapsulated in N-2-hydroxypropyl dimethylethyl ammonium chloride chitosan nanoparticles

Z Jin, D Li, C Dai, G Cheng, X Wang, K Zhao - Carbohydrate polymers, 2017 - Elsevier
We have synthesized N-2-hydroxypropyl dimethylethyl ammonium chloride chitosan (N-2-
HFCC) with higher water solubility than chitosan. To evaluate its potential as delivery carrier …

Pattern recognition receptors for respiratory syncytial virus infection and design of vaccines

R Zeng, Y Cui, Y Hai, Y Liu - Virus research, 2012 - Elsevier
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract illness in
infants and young children. Host immune response has been implicated in both the …